Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer

NCT00095199 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

939

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Pemetrexed
BIOLOGICAL: Cetuximab
DRUG: Docetaxel

Sponsor

Eli Lilly and Company